Fildena 50, which contains sildenafil, is primarily studied in patients with erectile dysfunction (ED). The demographics most commonly included in clinical trials typically consist of:
Age: Most studies focus on adult men, often ranging from 18 to 65 years, with a significant number of participants being older adults.
Underlying Health Conditions: Many trials include patients with comorbidities such as diabetes, hypertension, and cardiovascular disease, as these conditions can impact erectile function.
Severity of ED: Participants often represent a range of Fildena 50 mg severity, from mild to severe, to assess the medication's effectiveness across different levels of dysfunction.
Ethnicity and Geography: Studies often aim for a diverse demographic, including various ethnic backgrounds, though specific representations can vary by trial.
Psychological Factors: Some trials consider psychological aspects, including anxiety and depression, as these can affect erectile function.
These demographics help in understanding the Fildena 50 drug's efficacy and safety across different patient populations.
Add your comment